share_log

Piper Sandler Maintains Overweight on Cardiff Oncology, Raises Price Target to $10

Benzinga ·  Dec 13, 2024 21:14  · Ratings

Piper Sandler analyst Joseph Catanzaro maintains Cardiff Oncology (NASDAQ:CRDF) with a Overweight and raises the price target from $7 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment